Headquartered in Lachen near Zurich, Switzerland, the Octapharma Group is a leading company in the worldwide market for therapeutic human proteins. Working at Octapharma means to have an opportunity to contribute to our common goal – developing lifesaving therapies to improve patients’ lives.
We are seeking a motivated professional to join the International Business Unit Critical Care as International Medical Customer Manager. You are committed to the value for physicians and patients. In this role you will be responsible for planning, implementation and execution of post marketing medical and clinical projects for the critical care portfolio. You will work with local Sales & Marketing organizations to improve level of knowledge and quality of communication. You will continuously collect customer insights and develop relevant projects addressing unmet medical needs. You will structure and execute medical training and prepare education to external and internal audience. You will report to the Head of International Business Unit Critical Care.
Your main responsibilities and opportunities
Your Profile
Our offer
How to apply Please e-mail your application in English describing your interest, expected salary and enclosing your CV, references and/or recommendation letters to:
|
About Octapharma The vision of Octapharma is “Our passion drives us to provide new health solutions advancing human life”. Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. As a family-owned company, Octapharma believes in investing to make a difference in people’s lives and has been doing so since 1983; because it’s in our blood.Our company values are Ownership, Integrity, Leadership, Sustainability and Entrepreneurship. In 2018, the Group achieved €1.8 billion in revenue, an operating income of €346 million and invested €240 million to ensure future prosperity. Octapharma employs more than 8 300 people worldwide to support the treatment of patients in 115 countries with products across three therapeutic areas:
Octapharma owns six state-of-the-art production facilities in Austria, France, Germany, Mexico and Sweden. For more information visit www.octapharma.com |